Dapsone induced eosinophilic pneumonia

被引：0

作者：

Adar, T. ^{[1
,2
]}

Tayer-Shifman, O. ^{[1
]}

Mizrahi, M. ^{[1
]}

Tavdi, S. ^{[1
]}

Barak, O. ^{[1
]}

Shalit, M. ^{[3
]}

机构：

[1] Hadassah Hebrew Univ Med Ctr Jerusalem, Internal Med A Dept Med, Jerusalem, Israel

[2] Shaare Zedek Med Ctr, Inst Digest Dis, 12 Bayit St, IL-91031 Jerusalem, Israel

[3] Hadassah Hebrew Univ Med Ctr, Dept Med, Allergy & Clin Immunol Unit, Jerusalem, Israel

来源：

EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY | 2012年 / 44卷 / 03期

关键词：

Eosinophilic pneumonia; Dapsone; leprosy;

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Eosinophilic lung diseases (ELD) are a variety of several clinical entities, which may result from different etiologies, including drug treatment. Dapsone, a sulfone antibiotic widely used in leprosy (among other indications), has been described as a possible cause of ELD. We report a patient with leprosy who presented with respiratory symptoms and pulmonary infiltrates and was diagnosed as suffering from eosinophilic pneumonia. To the best of our knowledge, this is the first report in which the diagnosis of dapsone-induced eosinophilic pneumonia was supported by bronchoalveolar lavage, lung biopsy and typical response to therapy.

引用

页码：144 / 146

页数：3

共 50 条

[31] Idiopathic chronic eosinophilic pneumonia
Eric Marchand
Jean-François Cordier
Orphanet Journal of Rare Diseases, 1
[32] Eosinophilic pneumonia: Diagnosis and management
Cottin, V.
REVUE FRANCAISE D ALLERGOLOGIE, 2012, 52 (03): : 128 - 133
[33] Idiopathic Chronic Eosinophilic Pneumonia
Teixeira, Natalia
Santos, Maria Ines
Pedro, Filipa
Pinto, Maria Joao
Mestre, Ana
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (03)
[34] Tracheobronchial lesions in eosinophilic pneumonia
Matsuda, Yoshinobu
Tachibana, Kazunobu
Sasaki, Yumiko
Tsuyuguchi, Kazunari
Kitaichi, Masanori
Inoue, Yoshikazu
RESPIRATORY INVESTIGATION, 2014, 52 (01) : 21 - 27
[35] Dapsone induced methaemoglobinaemia
Landers, D
Bergin, C
OLeary, A
Merry, C
Keating, S
Mulcahy, F
INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 (06) : 445 - 447
[36] Risk Factors of Daptomycin-Induced Eosinophilic Pneumonia in a Population with Osteoarticular Infection
Soldevila-Boixader, Laura
Villanueva, Bernat
Ulldemolins, Marta
Benavent, Eva
Padulles, Ariadna
Ribera, Alba
Borras, Irene
Ariza, Javier
Murillo, Oscar
ANTIBIOTICS-BASEL, 2021, 10 (04):
[37] Eosinophile Pneumonie als unerwünschte ArzneimittelwirkungDrug-induced eosinophilic pneumonia
J. Schelhorn
L. Höfer
G. Syrbe
U. Polzer
Der Nervenarzt, 2008, 79 (6) : 696 - 698
[38] Unexpected Outcome of Daptomycin-induced Eosinophilic Pneumonia: Rarity Within a Rarity
Raza, Ahmad
Arslan, Ahmad
Atiq, Muhammad Umair
Chan, Vincent
Patel, Rajesh Kumar
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
[39] A Severe Case of Isotretinoin Induced Eosinophilic Pneumonia and Pericardial Effusion, a Case Report
Kampman, Anne
Keulers, Laurien
van der Maten, Jan
van der Meij, Jacqueline
Bethlehem, Carina
CURRENT DRUG SAFETY, 2025, 20 (01) : 74 - 77
[40] Multifocal Pneumonia Amidst the Global COVID-19 Pandemic: A Case of Daptomycin-Induced Eosinophilic Pneumonia
Watts, Abi
Gahona, Christian C. Toquica
Raj, Kavin
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)

← 1 2 3 4 5 →